Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logothetis

Showing results (831-840 of 1,104) with videos related to

Pageof 111
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patientsC J Logothetis, D A Swanson, F Dexeus, et al.
The Journal of Urology|July 29, 2020
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active SurveillanceJustin R Gregg, Devaki Shilpa Surasi, Alexandria Childs, et al.
Cancer|October 10, 2006
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinomaNizar M Tannir, Lorenzo Cohen, Xuemei Wang, et al.
Oncoimmunology|December 15, 2018
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohortQinchuan Wang, Justin R Gregg, Jian Gu, et al.
Urologic Oncology|December 13, 2003
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP)Shi-Ming Tu, Randall E Millikan, Lance C Pagliaro, et al.
Current Pharmaceutical Biotechnology|November 7, 2014
G protein-coupled receptor signaling to Kir channels in Xenopus oocytesCandice Hatcher-Solis, Miguel Fribourg, Katerina Spyridaki, et al.
Plos One|July 23, 2013
Loss of Notch1 disrupts the barrier repair in the corneal epitheliumAsadolah Movahedan, Neda Afsharkhamseh, Hossein M Sagha, et al.
Channels (Austin, Tex.)|October 5, 2017
Ca<sup>2+</sup>-Calmodulin and PIP2 interactions at the proximal C-terminus of Kv7 channelsWilliam S Tobelaim, Meidan Dvir, Guy Lebel, et al.
Molecular Cancer Research : MCR|December 7, 2011
Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancerGuang Yang, Alexei A Goltsov, Chengzhen Ren, et al.
Oncotarget|October 31, 2015
Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancerHuakang Tu, Jian Gu, Qing H Meng, et al.
Pageof 111

Showing results (831-840 of 1,104) with videos related to

Sort By:
Pageof 111
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patientsC J Logothetis, D A Swanson, F Dexeus, et al.
The Journal of Urology|July 29, 2020
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active SurveillanceJustin R Gregg, Devaki Shilpa Surasi, Alexandria Childs, et al.
Cancer|October 10, 2006
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinomaNizar M Tannir, Lorenzo Cohen, Xuemei Wang, et al.
Oncoimmunology|December 15, 2018
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohortQinchuan Wang, Justin R Gregg, Jian Gu, et al.
Urologic Oncology|December 13, 2003
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP)Shi-Ming Tu, Randall E Millikan, Lance C Pagliaro, et al.
Current Pharmaceutical Biotechnology|November 7, 2014
G protein-coupled receptor signaling to Kir channels in Xenopus oocytesCandice Hatcher-Solis, Miguel Fribourg, Katerina Spyridaki, et al.
Plos One|July 23, 2013
Loss of Notch1 disrupts the barrier repair in the corneal epitheliumAsadolah Movahedan, Neda Afsharkhamseh, Hossein M Sagha, et al.
Channels (Austin, Tex.)|October 5, 2017
Ca<sup>2+</sup>-Calmodulin and PIP2 interactions at the proximal C-terminus of Kv7 channelsWilliam S Tobelaim, Meidan Dvir, Guy Lebel, et al.
Molecular Cancer Research : MCR|December 7, 2011
Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancerGuang Yang, Alexei A Goltsov, Chengzhen Ren, et al.
Oncotarget|October 31, 2015
Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancerHuakang Tu, Jian Gu, Qing H Meng, et al.
Pageof 111